Categories: Uncategorized

Anticoccidial Drugs Market Expansion 2024-2033

Market Size –
The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.19 billion in 2023 to $1.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.

The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors.

Order your report now for swift delivery @
https://thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

Scope Of Anticoccidial Drugs Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Anticoccidial Drugs Market Overview

Market Drivers –
The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.19 billion in 2023 to $1.27 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.

Market Trends –
Major companies operating in the anticoccidial drugs market focus on developing innovative solutions, such as zoalene-based solutions, to enhance efficacy, minimize resistance development, and address emerging challenges in poultry and livestock management. A zoalene-based solution includes zoalene as its active ingredient and is utilized to combat coccidiosis in poultry. For instance, in May 2021, Elanco Animal Health Incorporated, a US-based pharmaceutical company, introduced ZoaShielda, a zoalene-based solution designed to control coccidiosis in poultry effectively. It offers poultry producers a flexible and reliable product suitable for various seasons and operations. It provides the expected reliability for managing coccidiosis while offering operational flexibility to producers.

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Get an inside scoop of the anticoccidial drugs market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Regional Insights –
North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies –

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva SantÃ© Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

Table of Contents
1. Executive Summary
2. Anticoccidial Drugs Market Characteristics
3. Anticoccidial Drugs Market Trends And Strategies
4. Anticoccidial Drugs Market – Macro Economic Scenario
5. Global Anticoccidial Drugs Market Size and Growth
.
.
.
31. Anticoccidial Drugs Market Other Major And Innovative Companies
32. Global Anticoccidial Drugs Market Competitive Benchmarking
33. Global Anticoccidial Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Anticoccidial Drugs Market
35. Anticoccidial Drugs Market Future Outlook and Potential Analysis
36.Appendix